
Journal of Organometallic Chemistry p. 197 - 202 (1983)
Update date:2022-08-02
Topics:
Paradisi, Carmen
Schiavon, Gaetano
Nucleophilic attack of triphenylphosphine on tricarbonyl(1-3:5,6-η-cyclooctadienylium)ruthenium cation initially gives a phosphonium ion, which, during three weeks isomerizes to the dicarbonyl(4-6-η,1-?-cyclooctenediyl)triphenylphosphineruthenium cation. (This species was also obtained by two other routes.) Nucleophilic attack on the latter of I- gives dicarbonyl(4-6-η,1-?-cyclooctadienylium)iodoruthenium, which with AgPF6 gives the coordinatively unsaturated dicarbonyl(1-3:5,6-η-cyclooctadienylium)ruthenium cation as an intermediate.Reactions of this cation with triphenylphosphine and with hydride ion give rise, respectively, to dicarbonyl(1-3:5,6-η-cyclooctadienylium)triphenylphosphineruthenium hexafluorophosphate and the metallic hydride dicarbonyl(4-6-η,1-?-cyclooctadienylium)hydrideruthenium.
Contact:886 2 2541 0022
Address:8 Fl., No. 11, Sec. 1, Chung Shan North Rd., Taipei, Taiwan R.O.C.
KangZhiYuan Pharmaceutical Company Limited
Contact:(Sabrina)86-20-85273232
Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China
Contact:+86-519-86339586,13584329896
Address:Changzhou Scientific and Education Park
Jiangsu Zenji Pharmaceuticals LTD
Contact:+86-025-83172562; +1-224-888-1133(USA)
Address:No.5 Xinmofan Road
Chengdu Aslee Biopharmaceuticals, Inc
Contact:18608018419
Address:Chengdu Aslee Biopharmaceuticals, Inc
Doi:10.1023/A:1020820405232
(2002)Doi:10.1021/jo026890d
(2003)Doi:10.7164/antibiotics.29.554
(1976)Doi:10.1016/j.tetlet.2017.03.079
(2017)Doi:10.1021/jo0357770
(2004)Doi:10.1021/jo050800y
(2005)